Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific ABAT GABAT ENSG00000183044 4-aminobutyrate aminotransferase 16 8674565-8784575 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041528, HPA041690 Supportive Tissue enhanced 0 kidney: 90.0;liver: 142.4 cerebral cortex: 81.2 ABCC1 GS-X, MRP, MRP1 ENSG00000103222 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 16 15949577-16143074 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002380 Uncertain Supportive Plasma membrane Expressed in all testis: 19.3 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Supportive Group enriched 24 duodenum: 30.2;gallbladder: 24.7;kidney: 12.5;liver: 39.4;small intestine: 31.7 skin: 1.1 ABL1 ABL, c-ABL, JTK7, p150 ENSG00000097007 ABL proto-oncogene 1, non-receptor tyrosine kinase 9 130713946-130887675 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002686, HPA027251, HPA027280, HPA028409 Supportive Supportive Nucleus but not nucleoli Expressed in all endometrium: 40.0 ACE ACE1, CD143, DCP1 ENSG00000159640 Angiotensin I converting enzyme 17 63477061-63498380 Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002426, CAB002921, HPA029298 Supportive Group enriched 6 duodenum: 127.7;lung: 50.7;small intestine: 194.5;testis: 45.7 thyroid gland: 17.0 ACE2 ENSG00000130234 Angiotensin I converting enzyme 2 X 15561033-15602148 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000288, CAB026174 Supportive Tissue enhanced 0 duodenum: 138.6;small intestine: 186.9 gallbladder: 64.0 ADA ENSG00000196839 Adenosine deaminase 20 44619522-44652233 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001399, CAB004307, HPA023884 Supportive Supportive Plasma membrane, Cytoplasm Tissue enriched 14 duodenum: 356.6 lymph node: 26.2 ADH1A ADH1 ENSG00000187758 Alcohol dehydrogenase 1A (class I), alpha polypeptide 4 99276367-99291028 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009562, HPA047814, HPA060902 Supportive Tissue enriched 118 liver: 747.4 gallbladder: 6.3 ADH1B ADH2 ENSG00000196616 Alcohol dehydrogenase 1B (class I), beta polypeptide 4 99304964-99321442 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047814, HPA060902 Supportive Group enriched 6 adipose tissue: 863.8;liver: 1586.7 lung: 201.9 ADH1C ADH3 ENSG00000248144 Alcohol dehydrogenase 1C (class I), gamma polypeptide 4 99336492-99353027 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047814, HPA060902 Supportive Group enriched 6 colon: 232.4;duodenum: 395.6;liver: 455.2;rectum: 135.7;small intestine: 122.3;stomach: 332.1 gallbladder: 47.8 ADK AK ENSG00000156110 Adenosine kinase 10 74151185-74709303 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032876, HPA038391, HPA038409 Uncertain Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all thyroid gland: 74.6 ADRB1 ADRB1R ENSG00000043591 Adrenoceptor beta 1 10 114044056-114046908 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA067972 Supportive Tissue enhanced 0 placenta: 26.0 heart muscle: 8.6 AGTR1 AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R ENSG00000144891 Angiotensin II receptor, type 1 3 148697784-148743008 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA003596 Supportive Group enriched 5 adipose tissue: 28.7;adrenal gland: 34.3;liver: 33.6;placenta: 101.1 kidney: 9.5 AKR1C2 BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD ENSG00000151632 Aldo-keto reductase family 1, member C2 10 4922564-5135226 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB047304 Uncertain Expressed in all adipose tissue: 203.2 AKR1D1 SRD5B1 ENSG00000122787 Aldo-keto reductase family 1, member D1 7 138002324-138117986 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA057002 Supportive Supportive Nucleus but not nucleoli Tissue enriched 137 liver: 165.3 testis: 1.2 ALAD ALADH, PBGS ENSG00000148218 Aminolevulinate dehydratase 9 113386317-113401333 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021023, HPA022124 Supportive Expressed in all adrenal gland: 93.7 ALPPL2 ENSG00000163286 Alkaline phosphatase, placental-like 2 2 232406843-232410714 Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020698, HPA038764, HPA038765, HPA051699 Supportive Tissue enhanced 0 fallopian tube: 0.7;placenta: 2.4 lung: 0.6 AMY2A AMY2 ENSG00000243480 Amylase, alpha 2A (pancreatic) 1 103616811-103625780 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045394, HPA045399, CAB045960, HPA046980 Supportive Tissue enriched 133 pancreas: 17135.9 salivary gland: 128.6 ANXA1 ANX1, LPC1 ENSG00000135046 Annexin A1 9 73151757-73170393 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011271, HPA011272, CAB013023, CAB035987, CAB058693 Supportive Supportive Plasma membrane, Cytoplasm, Nucleus but not nucleoli, Nuclear membrane Expressed in all esophagus: 5578.1 AOC3 HPAO, VAP-1, VAP1 ENSG00000131471 Amine oxidase, copper containing 3 17 42851184-42858130 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000980, CAB025797 Supportive Expressed in all adipose tissue: 286.7 APEX1 APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1 ENSG00000100823 APEX nuclease (multifunctional DNA repair enzyme) 1 14 20455191-20457772 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000956, HPA002564, CAB004294, CAB047307 Supportive Supportive Nucleus Expressed in all ovary: 123.4 AR AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1 ENSG00000169083 Androgen receptor X 67544032-67730619 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000001, CAB065764 Supportive Tissue enhanced 0 fallopian tube: 31.7 endometrium: 22.5 ATIC AICARFT, IMPCHASE, PURH ENSG00000138363 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase 2 215311817-215349773 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013462, HPA021012 Supportive Supportive Plasma membrane, Cytoplasm Expressed in all tonsil: 40.5 ATP2C1 ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1 ENSG00000017260 ATPase, Ca++ transporting, type 2C, member 1 3 130850595-131016712 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010207, HPA035116, HPA053533 Supportive Uncertain Cytoplasm, Nucleus, Golgi apparatus Expressed in all prostate: 72.0 ATP4A ATP6A ENSG00000105675 ATPase, H+/K+ exchanging, alpha polypeptide 19 35550043-35563658 Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039154 Supportive Tissue enriched 196 stomach: 361.8 pancreas: 1.8 ATP6V1B2 ATP6B2, HO57, VATB, Vma2, VPP3 ENSG00000147416 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 8 20197367-20226819 FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008147 Supportive Supportive Vesicles Expressed in all cerebral cortex: 156.4 BCL2 Bcl-2, PPP1R50 ENSG00000171791 B-cell CLL/lymphoma 2 18 63123346-63320128 Cancer-related genes, Disease related genes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000003 Uncertain Expressed in all thyroid gland: 41.1 BCR ALL, BCR1, CML, D22S11, D22S662, PHL ENSG00000186716 Breakpoint cluster region 22 23179704-23318037 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010421, CAB018545, HPA038337 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm Expressed in all cerebral cortex: 21.7 BLVRB FLR, SDR43U1 ENSG00000090013 Biliverdin reductase B (flavin reductase (NADPH)) 19 40447789-40465840 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041698, HPA041937 Supportive Supportive Plasma membrane, Cytoplasm, Nucleus but not nucleoli Expressed in all bone marrow: 295.2 BRAF BRAF1 ENSG00000157764 B-Raf proto-oncogene, serine/threonine kinase 7 140719327-140924764 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001328, CAB004552, HPA071048 Uncertain Uncertain Vesicles, Cytoplasm Expressed in all testis: 18.6 C3 ARMD9, C3a, C3b, CPAMD1 ENSG00000125730 Complement component 3 19 6677704-6730562 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003563, CAB004209, HPA020432 Supportive Tissue enriched 6 liver: 2172.5 adipose tissue: 386.5 CA1 Car1 ENSG00000133742 Carbonic anhydrase I 8 85327608-85379014 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006558, CAB025790 Supportive Group enriched 42 bone marrow: 1109.5;colon: 743.6;rectum: 1797.1 smooth muscle: 28.8 CA14 ENSG00000118298 Carbonic anhydrase XIV 1 150257159-150265078 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008482 Uncertain Tissue enhanced 0 cerebral cortex: 4.9;skeletal muscle: 6.6 skin: 2.2 CA2 CA-II, CAII, Car2 ENSG00000104267 Carbonic anhydrase II 8 85463852-85481493 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001550, CAB010102 Supportive Tissue enhanced 0 colon: 506.8;rectum: 487.4;stomach: 710.8 duodenum: 197.6 CA3 CAIII, Car3 ENSG00000164879 Carbonic anhydrase III, muscle specific 8 85373436-85449040 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004967, HPA021775, HPA026700 Supportive Tissue enriched 14 skeletal muscle: 1432.6 prostate: 104.3 CA4 CAIV, Car4, RP17 ENSG00000167434 Carbonic anhydrase IV 17 60149936-60170899 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011089, HPA017258 Supportive Supportive Vesicles Tissue enhanced 0 colon: 164.3;rectum: 131.0 adipose tissue: 53.8 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supportive Uncertain Golgi apparatus, Vesicles, Nucleus but not nucleoli Tissue enhanced 0 cerebral cortex: 7.9;stomach: 4.9 adrenal gland: 1.5 CACNA1C CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS ENSG00000151067 Calcium channel, voltage-dependent, L type, alpha 1C subunit 12 1970786-2697950 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039796 Supportive Tissue enhanced 0 heart muscle: 17.7;smooth muscle: 17.2 endometrium: 12.7 CACNA1S CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5 ENSG00000081248 Calcium channel, voltage-dependent, L type, alpha 1S subunit 1 201039512-201112566 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009507, HPA048892, HPA056815 Supportive Tissue enriched 31 skeletal muscle: 76.8 esophagus: 2.4 CACNA2D1 CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3 ENSG00000153956 Calcium channel, voltage-dependent, alpha 2/delta subunit 1 7 81946444-82443798 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008213, HPA008621 Supportive Mixed skeletal muscle: 21.1 CASR FHH, GPRC2A, HHC, HHC1, NSHPT ENSG00000036828 Calcium-sensing receptor 3 122183683-122286503 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039686, HPA050335 Supportive Tissue enhanced 0 gallbladder: 4.9;kidney: 16.8 stomach: 3.2 CAT ENSG00000121691 Catalase 11 34438925-34472062 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001515, HPA051282, HPA055838 Supportive Supportive Vesicles Expressed in all liver: 373.1 CCND1 BCL1, D11S287E, PRAD1, U21B31 ENSG00000110092 Cyclin D1 11 69641087-69654474 Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000024, HPA027801 Uncertain Supportive Nucleus but not nucleoli Expressed in all skin: 86.7 CD2 SRBC ENSG00000116824 CD2 molecule 1 116754385-116769228 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002430, HPA003883 Supportive Supportive Nucleus but not nucleoli, Nucleoli Tissue enhanced 0 lymph node: 94.5 tonsil: 60.6 CD247 CD3H, CD3Q, CD3Z ENSG00000198821 CD247 molecule 1 167430640-167518610 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004651, HPA008750 Supportive Tissue enhanced 0 lymph node: 51.5 tonsil: 32.6 CD33 FLJ00391, p67, SIGLEC-3, SIGLEC3 ENSG00000105383 CD33 molecule 19 51225064-51243860 CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011442, HPA035832, HPA064807 Uncertain Supportive Nucleus, Plasma membrane Mixed spleen: 20.1 CD3D T3D ENSG00000167286 CD3d molecule, delta (CD3-TCR complex) 11 118338954-118342744 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013055 Supportive Tissue enhanced 0 lymph node: 130.9;tonsil: 95.8 appendix: 53.3 CD3E ENSG00000198851 CD3e molecule, epsilon (CD3-TCR complex) 11 118304545-118316175 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000010, HPA040957, HPA043955, CAB072863, CAB072864 Supportive Tissue enhanced 0 lymph node: 162.1;tonsil: 109.6 appendix: 65.7 CD3G ENSG00000160654 CD3g molecule, gamma (CD3-TCR complex) 11 118344344-118355161 CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017520, HPA038494 Supportive Tissue enhanced 0 lymph node: 28.9;tonsil: 21.5 appendix: 11.7 CD4 ENSG00000010610 CD4 molecule 12 6786858-6820808 CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000011, HPA004252, HPA004472, CAB068180 Supportive Supportive Plasma membrane Expressed in all spleen: 132.3 CD44 CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1 ENSG00000026508 CD44 molecule (Indian blood group) 11 35138870-35232402 Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000112, CAB000316, HPA005785 Supportive Supportive Plasma membrane, Golgi apparatus Expressed in all skin: 307.2 CD80 B7-1, B7.1, CD28LG, CD28LG1 ENSG00000121594 CD80 molecule 3 119524293-119559602 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB025368, HPA050092 Supportive Tissue enhanced 0 appendix: 4.1;lymph node: 4.5;tonsil: 5.0 spleen: 2.1 CD86 B7-2, B7.2, CD28LG2 ENSG00000114013 CD86 molecule 3 122055366-122121139 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004319 Uncertain Mixed appendix: 31.6 CES1 CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1 ENSG00000198848 Carboxylesterase 1 16 55802851-55833337 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012023, HPA046717 Supportive Supportive Endoplasmic reticulum, Cytoplasm Expressed in all liver: 910.7 CFTR ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR ENSG00000001626 Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) 7 117465784-117715971 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001951, HPA021939 Supportive Tissue enhanced 0 gallbladder: 51.1;pancreas: 41.7 rectum: 36.9 CHD1 ENSG00000153922 Chromodomain helicase DNA binding protein 1 5 98853985-98928957 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA022236 Uncertain Supportive Nucleus, Nucleoli Expressed in all bone marrow: 28.6 CHRM1 ENSG00000168539 Cholinergic receptor, muscarinic 1 11 62908679-62921807 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014101, CAB022366 Supportive Uncertain Nucleus, Cytoplasm Group enriched 8 cerebral cortex: 19.6;prostate: 23.5;salivary gland: 12.0 adrenal gland: 2.3 CHRM3 ENSG00000133019 Cholinergic receptor, muscarinic 3 1 239386565-239915452 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010409, HPA024106, HPA048036 Uncertain Supportive Plasma membrane Mixed salivary gland: 9.4 CHRNA7 ENSG00000175344 Cholinergic receptor, nicotinic, alpha 7 (neuronal) 15 32030488-32172521 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA029422, CAB033624 Supportive Mixed small intestine: 6.0 CKB CKBB ENSG00000166165 Creatine kinase, brain 14 103519659-103523111 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001254, CAB047313 Supportive Supportive Cytoplasm Expressed in all prostate: 248.2 CKM CKMM ENSG00000104879 Creatine kinase, muscle 19 45306414-45322977 Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047859 Supportive Uncertain Vesicles, Nucleus Tissue enriched 16 skeletal muscle: 18173.4 heart muscle: 1142.4 CLCN2 ClC-2, CLC2, EJM6 ENSG00000114859 Chloride channel, voltage-sensitive 2 3 184346185-184361651 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009397, HPA014545, HPA024108 Supportive Mixed testis: 13.5 COMT ENSG00000093010 Catechol-O-methyltransferase 22 19941607-19969975 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001169, CAB011233 Supportive Uncertain Vesicles, Endoplasmic reticulum Expressed in all placenta: 143.1 CPS1 ENSG00000021826 Carbamoyl-phosphate synthase 1, mitochondrial 2 210477682-210679107 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003781, HPA021400 Supportive Uncertain Nucleoli Group enriched 33 duodenum: 166.9;liver: 441.1;small intestine: 99.4 testis: 7.0 CPT1A CPT1, CPT1-L, L-CPT1 ENSG00000110090 Carnitine palmitoyltransferase 1A (liver) 11 68754620-68844410 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008835 Supportive Supportive Mitochondria Expressed in all colon: 56.9 CPT2 CPT1, CPTASE ENSG00000157184 Carnitine palmitoyltransferase 2 1 53196429-53214197 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028201, HPA028202, HPA028214 Supportive Supportive Nucleoli, Nucleus but not nucleoli, Mitochondria Expressed in all liver: 25.5 CSF3R CD114, GCSFR ENSG00000119535 Colony stimulating factor 3 receptor (granulocyte) 1 36466043-36483278 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB017116, HPA048086 Supportive Tissue enhanced 0 appendix: 129.5;bone marrow: 209.9;placenta: 107.7 spleen: 65.5 CYP11B1 CPN1, CYP11B, FHI, P450C11 ENSG00000160882 Cytochrome P450, family 11, subfamily B, polypeptide 1 8 142872356-142879846 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049171, HPA056348, HPA057752 Supportive Tissue enriched 891 adrenal gland: 1057.2 testis: 1.1 CYP17A1 CPT7, CYP17, P450C17, S17AH ENSG00000148795 Cytochrome P450, family 17, subfamily A, polypeptide 1 10 102830531-102837533 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048533 Supportive Tissue enriched 31 adrenal gland: 2857.9 testis: 93.6 CYP19A1 ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM ENSG00000137869 Cytochrome P450, family 19, subfamily A, polypeptide 1 15 51208057-51338610 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000355, HPA051194 Supportive Uncertain Vesicles Tissue enriched 22 placenta: 145.0 adrenal gland: 6.6 CYP51A1 CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1 ENSG00000001630 Cytochrome P450, family 51, subfamily A, polypeptide 1 7 92112151-92142952 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041325, HPA043508 Uncertain Supportive Endoplasmic reticulum Expressed in all liver: 63.6 DBH DBM ENSG00000123454 Dopamine beta-hydroxylase (dopamine beta-monooxygenase) 9 133636360-133659344 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005960 Uncertain Tissue enriched 15 adrenal gland: 208.3 liver: 14.0 DDC AADC ENSG00000132437 Dopa decarboxylase (aromatic L-amino acid decarboxylase) 7 50458436-50565457 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017742 Supportive Uncertain Cytoskeleton (Actin filaments) Tissue enhanced 0 duodenum: 117.0;kidney: 221.5;small intestine: 126.5 adrenal gland: 41.2 DHODH ENSG00000102967 Dihydroorotate dehydrogenase (quinone) 16 72008588-72027664 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010123, HPA011942 Supportive Supportive Nucleus but not nucleoli, Mitochondria Expressed in all liver: 17.6 DNMT1 CXXC9, DNMT, MCMT ENSG00000130816 DNA (cytosine-5-)-methyltransferase 1 19 10133345-10231286 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002694, CAB005876 Supportive Supportive Nucleus but not nucleoli Expressed in all placenta: 39.6 DPEP1 ENSG00000015413 Dipeptidase 1 (renal) 16 89613308-89638456 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009426, HPA012783 Supportive Tissue enhanced 0 kidney: 276.1;small intestine: 266.5 pancreas: 101.4 DPP4 ADCP2, CD26, DPPIV ENSG00000197635 Dipeptidyl-peptidase 4 2 161992241-162074542 CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB045970 Supportive Tissue enhanced 0 small intestine: 92.9 placenta: 77.4 DRD5 DRD1B, DRD1L2 ENSG00000169676 Dopamine receptor D5 4 9781680-9784009 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA048930 Supportive Group enriched 8 appendix: 1.1;cerebral cortex: 0.9 prostate: 0.1 EDNRA ENSG00000151617 Endothelin receptor type A 4 147480917-147544954 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013774, HPA014087, CAB018957 Supportive Uncertain Cytoplasm, Nucleus but not nucleoli, Plasma membrane Mixed endometrium: 40.4 EGFR ERBB, ERBB1 ENSG00000146648 Epidermal growth factor receptor 7 55019021-55256620 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000035, HPA001200, HPA018530, CAB068186, CAB073534 Supportive Supportive Plasma membrane Tissue enhanced 0 placenta: 61.3 skin: 35.8 ELANE ELA2, HLE, HNE, NE ENSG00000197561 Elastase, neutrophil expressed 19 851014-856247 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015409 Supportive Tissue enriched 471 bone marrow: 1925.8 skin: 4.0 EPHA2 ECK ENSG00000142627 EPH receptor A2 1 16124337-16156087 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010464 Uncertain Tissue enhanced 0 esophagus: 63.2 urinary bladder: 32.3 ERBB2 CD340, HER-2, HER2, NEU, NGL ENSG00000141736 V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 17 39687914-39730426 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000043, HPA001338, HPA001383, CAB020416, CAB062555 Uncertain Supportive Nucleus, Plasma membrane, Cytoplasm Expressed in all esophagus: 69.5 ESR1 Era, ESR, NR3A1 ENSG00000091831 Estrogen receptor 1 6 151656691-152129619 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB000037, HPA000449, HPA000450, CAB055099, CAB072858 Supportive Uncertain Vesicles, Nucleus Group enriched 12 endometrium: 161.0;fallopian tube: 142.0;smooth muscle: 113.7 ovary: 12.0 F2 ENSG00000180210 Coagulation factor II (thrombin) 11 46719180-46739506 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016780, CAB018650, HPA051476, HPA054698 Supportive Tissue enriched 2559 liver: 514.8 gallbladder: 0.2 F8 DXS1253E, F8C, FVIII, HEMA ENSG00000185010 Coagulation factor VIII, procoagulant component X 154835788-155026940 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018777 Supportive Expressed in all adipose tissue: 15.0 FASN FAS, SDR27X1 ENSG00000169710 Fatty acid synthase 17 82078338-82098332 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005192, HPA006461, CAB015417, HPA056108 Supportive Supportive Cytoplasm, Plasma membrane Tissue enriched 5 adipose tissue: 170.3 prostate: 32.1 FCER1A FCE1A ENSG00000179639 Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide 1 159289714-159308224 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB022102 Supportive Mixed skin: 22.8 FCER1G ENSG00000158869 Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide 1 161215234-161220699 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022108, HPA026872 Supportive Expressed in all appendix: 247.3 FCGR2A CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2 ENSG00000143226 Fc fragment of IgG, low affinity IIa, receptor (CD32) 1 161505430-161524013 CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010718, HPA014730 Supportive Mixed appendix: 80.9 FCGR2B CD32, CD32B, FCG2, FCGR2 ENSG00000072694 Fc fragment of IgG, low affinity IIb, receptor (CD32) 1 161581311-161678654 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007796, HPA014730 Supportive Tissue enriched 8 placenta: 170.4 tonsil: 20.1 FCGR3A CD16, CD16a, FCG3, FCGR3 ENSG00000203747 Fc fragment of IgG, low affinity IIIa, receptor (CD16a) 1 161541759-161550737 CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032435, HPA055431 Supportive Expressed in all spleen: 203.8 FDPS ENSG00000160752 Farnesyl diphosphate synthase 1 155308748-155320666 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028200 Uncertain Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all liver: 119.5 FGA ENSG00000171560 Fibrinogen alpha chain 4 154583126-154590766 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016776, HPA051370, HPA064755 Supportive Tissue enriched 273 liver: 5995.6 stomach: 21.9 FGF1 AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1 ENSG00000113578 Fibroblast growth factor 1 (acidic) 5 142592178-142698070 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003265, CAB017519 Supportive Supportive Nucleus but not nucleoli Group enriched 6 cerebral cortex: 64.9;heart muscle: 32.2;kidney: 41.4 adipose tissue: 7.1 FGF2 FGFB ENSG00000138685 Fibroblast growth factor 2 (basic) 4 122826708-122898236 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000125 Uncertain Supportive Nucleus Mixed adipose tissue: 17.4 FGFR2 BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 ENSG00000066468 Fibroblast growth factor receptor 2 10 121478334-121598458 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010886, HPA035305, HPA056562 Uncertain Supportive Vesicles, Cell Junctions, Nucleus Mixed skin: 56.0 FLT1 FLT, VEGFR1 ENSG00000102755 Fms-related tyrosine kinase 1 13 28300344-28495128 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011740, HPA014290, CAB068189, CAB068190 Supportive Tissue enriched 8 placenta: 341.0 thyroid gland: 44.8 FLT4 PCL, VEGFR3 ENSG00000037280 Fms-related tyrosine kinase 4 5 180601506-180649624 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000099 Supportive Nucleus but not nucleoli, Plasma membrane, Cell Junctions Mixed spleen: 12.8 FN1 CIG, FINC, GFND2, LETS, MSF ENSG00000115414 Fibronectin 1 2 215360440-215436172 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000126, HPA027066 Supportive Tissue enhanced 0 placenta: 2101.5 liver: 721.6 FOLH1 FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA ENSG00000086205 Folate hydrolase (prostate-specific membrane antigen) 1 11 49146635-49208670 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001451, HPA010593 Supportive Tissue enhanced 0 duodenum: 203.1;prostate: 83.3 small intestine: 60.1 FRK GTK, PTK5, RAK ENSG00000111816 Fyn-related Src family tyrosine kinase 6 115931149-116060758 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025217, HPA069346 Uncertain Supportive Nucleus, Vesicles Mixed kidney: 5.6 FTL MGC71996, NBIA3 ENSG00000087086 Ferritin, light polypeptide 19 48965301-48966878 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020769, HPA041602 Supportive Uncertain Cytoplasm Expressed in all kidney: 3106.3 FXYD2 ATP1G1, HOMG2, MGC12372 ENSG00000137731 FXYD domain containing ion transport regulator 2 11 117800844-117828698 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004649, HPA068838 Supportive Tissue enhanced 0 gallbladder: 363.6;kidney: 1240.4;salivary gland: 418.6 pancreas: 135.6 GAA ENSG00000171298 Glucosidase, alpha; acid 17 80101556-80119879 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026970, HPA029126 Supportive Expressed in all placenta: 50.2 GABBR2 GABABR2, GPR51, GPRC3B, HG20 ENSG00000136928 Gamma-aminobutyric acid (GABA) B receptor, 2 9 98288109-98709197 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013820, HPA031684 Supportive Tissue enriched 14 cerebral cortex: 45.8 adrenal gland: 3.1 GABRA1 EJM5 ENSG00000022355 Gamma-aminobutyric acid (GABA) A receptor, alpha 1 5 161847191-161899969 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022502, HPA055746 Supportive Tissue enriched 44 cerebral cortex: 60.7 adrenal gland: 1.3 GABRB2 ENSG00000145864 Gamma-aminobutyric acid (GABA) A receptor, beta 2 5 161288429-161549044 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001964, HPA067632 Supportive Tissue enriched 14 cerebral cortex: 34.6 spleen: 2.4 GABRD ENSG00000187730 Gamma-aminobutyric acid (GABA) A receptor, delta 1 2019324-2030751 Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044371 Supportive Tissue enriched 7 cerebral cortex: 21.3 testis: 2.8 GANAB G2AN, GluII, KIAA0088 ENSG00000089597 Glucosidase, alpha; neutral AB 11 62624826-62646726 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026874, HPA061426 Supportive Supportive Endoplasmic reticulum, Nuclear membrane, Cytoplasm Expressed in all thyroid gland: 124.0 GART PGFT, PRGS ENSG00000159131 Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase 21 33503931-33543491 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002119, HPA005779 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm, Mitochondria Expressed in all tonsil: 32.7 GGPS1 GGPPS1 ENSG00000152904 Geranylgeranyl diphosphate synthase 1 1 235327350-235344532 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029472 Supportive Expressed in all testis: 42.1 GLP2R ENSG00000065325 Glucagon-like peptide 2 receptor 17 9822206-9892102 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA049244 Supportive Tissue enhanced 0 gallbladder: 11.2 duodenum: 7.7 GLRA2 GLR ENSG00000101958 Glycine receptor, alpha 2 X 14529298-14731812 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB070422 Supportive Group enriched 15 cerebral cortex: 3.3;colon: 1.5;rectum: 3.0 placenta: 0.1 GRIA1 GluA1, GLUR1, GLURA ENSG00000155511 Glutamate receptor, ionotropic, AMPA 1 5 153489615-153813869 FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001965, HPA035202 Supportive Tissue enriched 5 cerebral cortex: 35.6 lung: 6.9 GRIN2A GluN2A, NMDAR2A ENSG00000183454 Glutamate receptor, ionotropic, N-methyl D-aspartate 2A 16 9753409-10182754 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022725 Supportive Tissue enriched 6 cerebral cortex: 14.2 testis: 2.3 GSR ENSG00000104687 Glutathione reductase 8 30678061-30727926 Cancer-related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001538, CAB008632 Supportive Supportive Cytoplasm, Plasma membrane Expressed in all rectum: 46.8 GSS ENSG00000100983 Glutathione synthetase 20 34928430-34955817 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054508, HPA059315 Uncertain Supportive Nucleus Expressed in all rectum: 38.0 HBA1 HBA-T3 ENSG00000206172 Hemoglobin, alpha 1 16 176680-177522 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB032534, HPA043780 Supportive Tissue enriched 9 bone marrow: 8650.2 placenta: 920.8 HBA2 HBA-T2 ENSG00000188536 Hemoglobin, alpha 2 16 172847-173710 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB038417, HPA043780 Supportive Tissue enriched 10 bone marrow: 10019.5 placenta: 1052.3 HDAC1 GON-10, HD1, RPD3L1 ENSG00000116478 Histone deacetylase 1 1 32292086-32333635 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005017, HPA029693, CAB068191 Supportive Supportive Nucleus but not nucleoli Expressed in all tonsil: 104.2 HDAC2 RPD3, YAF1 ENSG00000196591 Histone deacetylase 2 6 113933028-114011308 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005054, HPA011727 Supportive Supportive Nucleus Expressed in all testis: 61.6 HDAC3 HD3, RPD3, RPD3-2 ENSG00000171720 Histone deacetylase 3 5 141620876-141636870 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005583, HPA052052 Supportive Supportive Nucleus but not nucleoli, Golgi apparatus Expressed in all tonsil: 37.6 HDAC6 FLJ16239, HD6, JM21, KIAA0901, PPP1R90 ENSG00000094631 Histone deacetylase 6 X 48801377-48824982 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003714, CAB004236, HPA026321 Supportive Expressed in all kidney: 32.7 HMGCR ENSG00000113161 3-hydroxy-3-methylglutaryl-CoA reductase 5 75336329-75362104 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008338, CAB016797 Supportive Expressed in all cerebral cortex: 44.0 HMMR CD168, RHAMM ENSG00000072571 Hyaluronan-mediated motility receptor (RHAMM) 5 163460203-163491945 CD markers, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002433, HPA040025, HPA043926 Supportive Supportive Cytoskeleton (Microtubules), Centrosome Tissue enhanced 0 testis: 22.2 lymph node: 15.9 HPD 4-HPPD, 4HPPD, GLOD3, PPD ENSG00000158104 4-hydroxyphenylpyruvate dioxygenase 12 121839527-121863596 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038321, HPA038322 Supportive Uncertain Nucleus but not nucleoli Group enriched 133 kidney: 311.0;liver: 828.9 testis: 4.2 HPRT1 HGPRT, HPRT ENSG00000165704 Hypoxanthine phosphoribosyltransferase 1 X 134460153-134520513 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006360, CAB012200 Supportive Supportive Cytoplasm Expressed in all testis: 70.2 HRH1 ENSG00000196639 Histamine receptor H1 3 11137093-11263557 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA029740 Uncertain Supportive Plasma membrane, Nucleus but not nucleoli, Cytoplasm Mixed urinary bladder: 8.6 HSD3B1 HSD3B, HSDB3, SDR11E1 ENSG00000203857 Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 1 119507198-119515054 Enzymes, FDA approved drug targets, Mitochondrial proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043261, HPA043264, HPA044028 Supportive Tissue enriched 17 placenta: 90.5 small intestine: 5.4 HSD3B2 SDR11E2 ENSG00000203859 Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 1 119414931-119423035 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043261, HPA043264, HPA044028 Supportive Tissue enriched 557 adrenal gland: 1546.1 testis: 2.7 HTR2A 5-HT2A, HTR2 ENSG00000102468 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13 46831550-46897076 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014011 Supportive Tissue enriched 7 cerebral cortex: 16.9 smooth muscle: 2.3 ICAM1 BB2, CD54 ENSG00000090339 Intercellular adhesion molecule 1 19 10270835-10286615 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002126, CAB002142, HPA004877 Supportive Uncertain Plasma membrane, Cytoplasm Expressed in all lung: 116.8 IDE ENSG00000119912 Insulin-degrading enzyme 10 92451684-92574076 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063478 Uncertain Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all skin: 39.0 IKBKB IKK-beta, IKK2, IKKB, NFKBIKB ENSG00000104365 Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 8 42271302-42332653 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001249, CAB004447 Supportive Supportive Cytoplasm Expressed in all urinary bladder: 12.6 IL2RA CD25, IDDM10, IL2R ENSG00000134460 Interleukin 2 receptor, alpha 10 6010689-6062325 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002419, HPA054622 Supportive Tissue enhanced 0 adipose tissue: 14.8;lymph node: 15.2 appendix: 12.0 IL2RB CD122, IL15RB ENSG00000100385 Interleukin 2 receptor, beta 22 37125838-37175054 Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051627, HPA062657 Supportive Uncertain Nucleus, Nucleoli Tissue enhanced 0 spleen: 45.6 lymph node: 29.2 IL2RG CD132, CIDX, IMD4, SCIDX1 ENSG00000147168 Interleukin 2 receptor, gamma X 71107404-71112108 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046641 Supportive Tissue enhanced 0 lymph node: 219.7;tonsil: 264.8 appendix: 125.4 IMPDH1 LCA11, RP10, sWSS2608 ENSG00000106348 IMP (inosine 5'-monophosphate) dehydrogenase 1 7 128392277-128410252 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001400, HPA058375 Uncertain Supportive Nucleus but not nucleoli, Cell Junctions Expressed in all adipose tissue: 28.6 IMPDH2 ENSG00000178035 IMP (inosine 5'-monophosphate) dehydrogenase 2 3 49024325-49029408 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001400, CAB020717 Uncertain Supportive Cytoplasm Expressed in all ovary: 292.8 INSR CD220 ENSG00000171105 Insulin receptor 19 7112255-7294034 CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036302, HPA036303 Uncertain Supportive Vesicles Expressed in all ovary: 24.6 ITGA2B CD41, CD41B, GP2B, PPP1R93 ENSG00000005961 Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) 17 44372180-44389505 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018611, HPA031168, HPA031169, HPA031170, HPA031171 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 bone marrow: 9.0 thyroid gland: 2.5 ITGAL CD11A, LFA-1 ENSG00000005844 Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) 16 30472658-30523185 CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025011 Supportive Tissue enhanced 0 lymph node: 57.8;spleen: 51.6 tonsil: 41.3 ITGAV CD51, MSK8, VNRA, VTNR ENSG00000138448 Integrin, alpha V 2 186590065-186680901 Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002499, HPA004856 Supportive Uncertain Cytoplasm, Focal Adhesions Expressed in all thyroid gland: 59.5 ITGB1 CD29, FNRB, GPIIA, MDF2, MSK12 ENSG00000150093 Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) 10 32900319-33005792 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003434 Uncertain Supportive Plasma membrane, Focal Adhesions, Endoplasmic reticulum Expressed in all smooth muscle: 448.9 ITGB3 CD61, GP3A, GPIIIa ENSG00000259207 Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) 17 47253846-47311816 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027852 Supportive Tissue enhanced 0 thyroid gland: 44.4 smooth muscle: 19.9 JAK3 JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK ENSG00000105639 Janus kinase 3 19 17824780-17848071 Cancer-related genes, Cytoskeleton related proteins, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070314 Supportive Tissue enhanced 0 appendix: 32.5;lymph node: 33.8 tonsil: 25.5 JUN AP-1, c-Jun ENSG00000177606 Jun proto-oncogene 1 58780788-58784327 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003801, CAB007780, HPA059474 Supportive Supportive Nucleus but not nucleoli Expressed in all prostate: 208.3 KCNA5 HK2, HPCN1, Kv1.5 ENSG00000130037 Potassium voltage-gated channel, shaker-related subfamily, member 5 12 5043989-5046788 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021516, CAB022562 Supportive Group enriched 5 esophagus: 4.0;heart muscle: 12.6 adipose tissue: 1.5 KCNB1 Kv2.1 ENSG00000158445 Potassium voltage-gated channel, Shab-related subfamily, member 1 20 49363877-49482647 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supportive Tissue enhanced 0 adipose tissue: 7.2;cerebral cortex: 10.8 fallopian tube: 4.7 KCNC1 Kv3.1 ENSG00000129159 Potassium voltage-gated channel, Shaw-related subfamily, member 1 11 17734812-17783055 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047634 Supportive Tissue enriched 6 cerebral cortex: 7.6 testis: 1.1 KCNC2 Kv3.2 ENSG00000166006 Potassium voltage-gated channel, Shaw-related subfamily, member 2 12 75040077-75209868 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019664, CAB022571 Uncertain Supportive Cytoplasm, Plasma membrane Tissue enriched 10 cerebral cortex: 19.2 prostate: 1.9 KCNJ1 Kir1.1, ROMK1 ENSG00000151704 Potassium inwardly-rectifying channel, subfamily J, member 1 11 128836315-128867373 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA026962 Supportive Tissue enriched 146 kidney: 108.2 skin: 0.7 KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA059318 Supportive Nucleus but not nucleoli, Plasma membrane Group enriched 9 adrenal gland: 2.4;cerebral cortex: 1.4 testis: 0.2 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium voltage-gated channel, KQT-like subfamily, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supportive Tissue enhanced 0 adrenal gland: 84.9;thyroid gland: 79.6 stomach: 42.4 KEAP1 INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454 ENSG00000079999 Kelch-like ECH-associated protein 1 19 10486120-10503741 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005558, CAB025337 Uncertain Supportive Nucleus but not nucleoli, Cytoplasm, Microtubule organizing center Expressed in all skeletal muscle: 37.7 KIT C-Kit, CD117, PBT, SCFR ENSG00000157404 V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 4 54657918-54740715 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003288, HPA004471, CAB068253, CAB072867 Supportive Mixed thyroid gland: 41.1 LCK ENSG00000182866 LCK proto-oncogene, Src family tyrosine kinase 1 32251239-32286165 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003494, CAB003816 Supportive Uncertain Golgi apparatus Tissue enhanced 0 lymph node: 89.5;tonsil: 63.6 appendix: 41.9 LIPF HGL, HLAL ENSG00000182333 Lipase, gastric 10 88664441-88678814 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045930 Supportive Tissue enriched 87 stomach: 17845.5 duodenum: 205.3 M6PR ENSG00000003056 Mannose-6-phosphate receptor (cation dependent) 12 8940363-8949955 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034464, HPA040445 Uncertain Expressed in all lymph node: 88.2 MAOA ENSG00000189221 Monoamine oxidase A X 43654907-43746824 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009437, HPA054807, HPA059299 Supportive Supportive Mitochondria Mixed small intestine: 178.7 MAOB ENSG00000069535 Monoamine oxidase B X 43766611-43882447 Enzymes, FDA approved drug targets, Mitochondrial proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002328, CAB037200 Supportive Uncertain Nucleoli, Mitochondria Mixed ovary: 130.8 MAP1A MAP1L ENSG00000166963 Microtubule-associated protein 1A 15 43510958-43531620 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039063, HPA039064 Supportive Uncertain Nucleus, Cytoplasm Tissue enriched 7 cerebral cortex: 82.9 smooth muscle: 11.0 MAP2 MAP2A, MAP2B, MAP2C ENSG00000078018 Microtubule-associated protein 2 2 209424058-209734118 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001984, HPA008273, HPA012828 Supportive Supportive Supportive Nucleoli, Cytoplasm Tissue enriched 9 cerebral cortex: 157.0 thyroid gland: 18.0 MAP2K1 MAPKK1, MEK1, PRKMK1 ENSG00000169032 Mitogen-activated protein kinase kinase 1 15 66386817-66492312 Cancer-related genes, Cytoskeleton related proteins, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003834, HPA026430 Supportive Supportive Plasma membrane, Cytoplasm Expressed in all cerebral cortex: 64.6 MAP2K2 MEK2, PRKMK2 ENSG00000126934 Mitogen-activated protein kinase kinase 2 19 4090321-4124129 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003835, HPA051993 Supportive Supportive Cytoplasm Expressed in all duodenum: 60.5 MAP4 ENSG00000047849 Microtubule-associated protein 4 3 47850690-48089272 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038149, HPA038150 Supportive Supportive Plasma membrane, Cytoplasm, Cytoskeleton (Microtubules) Expressed in all heart muscle: 185.0 MAPK1 ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2 ENSG00000100030 Mitogen-activated protein kinase 1 22 21754500-21867680 Cancer-related genes, Cytoskeleton related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003995, CAB004229, HPA005700, HPA030069 Supportive Supportive Nucleus but not nucleoli, Cytoskeleton (Microtubules) Expressed in all cerebral cortex: 67.0 MAPK3 ERK1, p44erk1, p44mapk, PRKM3 ENSG00000102882 Mitogen-activated protein kinase 3 16 30114105-30123506 Cancer-related genes, Cytoskeleton related proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002683, HPA003995, HPA005700, HPA030069 Supportive Supportive Nucleus but not nucleoli, Cytoskeleton (Microtubules) Expressed in all esophagus: 96.0 MAPT DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau ENSG00000186868 Microtubule-associated protein tau 17 45894382-46028334 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000151, HPA069524, HPA069570 Supportive Tissue enhanced 0 cerebral cortex: 126.4 kidney: 27.0 MET HGFR, RCCP2 ENSG00000105976 MET proto-oncogene, receptor tyrosine kinase 7 116672390-116798386 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005282, CAB018577, HPA055607 Uncertain Supportive Plasma membrane, Cytoplasm Expressed in all placenta: 23.3 METAP2 MAP2, MNPEP, p67 ENSG00000111142 Methionyl aminopeptidase 2 12 95473520-95515839 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013025, HPA019095 Supportive Supportive Plasma membrane, Cytoplasm Expressed in all tonsil: 105.9 MGAM MGA ENSG00000257335 Maltase-glucoamylase (alpha-glucosidase) 7 141907813-142106747 Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002270 Supportive Uncertain Cytoplasm, Nucleus, Nuclear membrane Group enriched 5 duodenum: 50.9;kidney: 16.5;small intestine: 72.5 bone marrow: 9.2 MME CALLA, CD10, NEP ENSG00000196549 Membrane metallo-endopeptidase 3 155024124-155183729 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000013, HPA052583, HPA056072 Supportive Tissue enhanced 0 duodenum: 291.0;kidney: 235.4;small intestine: 256.5 placenta: 82.8 MMP10 STMY2 ENSG00000166670 Matrix metallopeptidase 10 (stromelysin 2) 11 102770503-102780628 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002159 Supportive Plasma membrane, Cytoplasm Tissue enriched 31 endometrium: 208.0 appendix: 6.6 MMP15 MT2-MMP, MTMMP2, SMCP-2 ENSG00000102996 Matrix metallopeptidase 15 (membrane-inserted) 16 58025566-58046901 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002611, HPA040390 Uncertain Supportive Nucleus, Cytoplasm Mixed thyroid gland: 38.8 MMP8 CLG1 ENSG00000118113 Matrix metallopeptidase 8 (neutrophil collagenase) 11 102711795-102727050 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021221, HPA022935 Supportive Tissue enriched 142 bone marrow: 277.6 endometrium: 1.9 MMP9 CLG4B ENSG00000100985 Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) 20 46008908-46016561 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201 Supportive Uncertain Cytoplasm Tissue enhanced 0 bone marrow: 196.2;lymph node: 79.2 appendix: 48.4 MPL CD110, TPOR ENSG00000117400 MPL proto-oncogene, thrombopoietin receptor 1 43337807-43352772 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002011, HPA007619 Supportive Plasma membrane Not detected ovary: 0.4 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supportive Group enriched 13 appendix: 176.9;lymph node: 562.2;spleen: 290.3;tonsil: 731.0 urinary bladder: 33.2 MS4A2 APY, FCER1B, IGER, MS4A1 ENSG00000149534 Membrane-spanning 4-domains, subfamily A, member 2 11 60088261-60098466 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA059967 Supportive Mixed lung: 15.6 MTR cblG ENSG00000116984 5-methyltetrahydrofolate-homocysteine methyltransferase 1 236795281-236903981 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044474 Supportive Cytoplasm Expressed in all ovary: 14.0 MUT ENSG00000146085 Methylmalonyl CoA mutase 6 49430360-49463191 Disease related genes, Enzymes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035971, HPA035972 Supportive Uncertain Cytoplasm, Mitochondria Expressed in all liver: 63.5 NFKB1 KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50 ENSG00000109320 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 4 102501329-102617302 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004031, HPA027305 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all bone marrow: 43.2 NOS3 ECNOS, eNOS ENSG00000164867 Nitric oxide synthase 3 (endothelial cell) 7 150990995-151014588 Cancer-related genes, Cytoskeleton related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002168 Supportive Tissue enriched 8 spleen: 50.1 adipose tissue: 6.0 NOXO1 P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28 ENSG00000196408 NADPH oxidase organizer 1 16 1978917-1984192 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA071540 Supportive Tissue enhanced 0 appendix: 4.2;colon: 5.3;rectum: 4.9 small intestine: 1.9 NPC1L1 ENSG00000015520 NPC1-like 1 7 44512535-44541315 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB070127, CAB070128 Supportive Group enriched 5 duodenum: 41.0;liver: 12.2;small intestine: 38.0 gallbladder: 6.0 NR3C1 GR, GRL ENSG00000113580 Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) 5 143277931-143435512 Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004248, CAB010435 Supportive Supportive Nucleus but not nucleoli, Cytoplasm, Mitochondria Expressed in all placenta: 29.1 NR3C2 MLR, MR ENSG00000151623 Nuclear receptor subfamily 3, group C, member 2 4 148078762-148444698 Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009155 Supportive Expressed in all rectum: 23.5 OPRM1 MOR1 ENSG00000112038 Opioid receptor, mu 1 6 154010496-154246867 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014509, HPA067435 Supportive Supportive Tissue enhanced 0 adrenal gland: 0.9;testis: 1.8 cerebral cortex: 0.3 P2RY12 HORK3, P2Y12, SP1999 ENSG00000169313 Purinergic receptor P2Y, G-protein coupled, 12 3 151337380-151384812 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013796, HPA014518 Supportive Tissue enhanced 0 cerebral cortex: 37.7 lymph node: 8.3 PAH PH ENSG00000171759 Phenylalanine hydroxylase 12 102836885-102958410 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028407, HPA031642 Supportive Uncertain Endoplasmic reticulum, Vesicles Group enriched 108 gallbladder: 78.2;kidney: 277.6;liver: 364.3 testis: 2.2 PDE3A CGI-PDE ENSG00000172572 Phosphodiesterase 3A, cGMP-inhibited 12 20369245-20684381 Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014492 Uncertain Supportive Cytoplasm Tissue enhanced 0 heart muscle: 29.2 placenta: 14.5 PDE5A ENSG00000138735 Phosphodiesterase 5A, cGMP-specific 4 119494395-119628991 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004729, HPA012873 Supportive Uncertain Cytoplasm Expressed in all prostate: 48.2 PDE7A HCP1 ENSG00000205268 Phosphodiesterase 7A 8 65717510-65842322 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018770, HPA027340 Supportive Expressed in all lymph node: 51.2 PDE8B ENSG00000113231 Phosphodiesterase 8B 5 77210449-77429807 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036912 Supportive Uncertain Cytoplasm Tissue enriched 7 thyroid gland: 184.2 endometrium: 27.8 PDGFRB CD140b, JTK12, PDGFR, PDGFR1 ENSG00000113721 Platelet-derived growth factor receptor, beta polypeptide 5 150113837-150155872 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003842, CAB018144, HPA028499 Supportive Uncertain Cytoplasm, Vesicles Mixed gallbladder: 125.2 PDXK C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79 ENSG00000160209 Pyridoxal (pyridoxine, vitamin B6) kinase 21 43719094-43762307 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030196, HPA030197, HPA030198, CAB033918 Uncertain Supportive Nucleus Expressed in all cerebral cortex: 23.5 PGR NR3C3, PR ENSG00000082175 Progesterone receptor 11 101029624-101130524 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000068, HPA004751, HPA008428, HPA017176, CAB055100 Supportive Group enriched 6 endometrium: 80.2;fallopian tube: 28.3;smooth muscle: 62.6 ovary: 10.2 PLA2G1B PLA2, PLA2A, PPLA2 ENSG00000170890 Phospholipase A2, group IB (pancreas) 12 120322111-120327789 Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047822, HPA060803 Supportive Tissue enriched 405 pancreas: 24344.0 ovary: 60.1 PLA2G4A cPLA2-alpha, PLA2G4 ENSG00000116711 Phospholipase A2, group IVA (cytosolic, calcium-dependent) 1 186828953-186988981 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010050, HPA050062, HPA054206 Supportive Supportive Cytoplasm Mixed fallopian tube: 25.6 PLAT ENSG00000104368 Plasminogen activator, tissue 8 42175233-42207724 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003412, CAB009335 Supportive Uncertain Cytoskeleton (Actin filaments) Mixed urinary bladder: 114.6 PLAUR CD87, UPAR, URKR ENSG00000011422 Plasminogen activator, urokinase receptor 19 43646095-43670547 Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050843, CAB073533 Uncertain Supportive Plasma membrane Tissue enhanced 0 bone marrow: 379.5 gallbladder: 77.2 PLG ENSG00000122194 Plasminogen 6 160702238-160753315 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000668, CAB016678, HPA021602, HPA048823 Supportive Tissue enriched 6 liver: 1009.2 kidney: 171.4 PLIN3 M6PRBP1, PP17, TIP47 ENSG00000105355 Perilipin 3 19 4838341-4867768 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006427, HPA066538 Uncertain Supportive Vesicles Expressed in all esophagus: 82.5 PNLIP PL ENSG00000175535 Pancreatic lipase 10 116545931-116567855 Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062430, HPA062494 Supportive Tissue enriched 495 pancreas: 91916.7 ovary: 185.7 PNP NP, PUNP ENSG00000198805 Purine nucleoside phosphorylase 14 20468954-20477094 Cytoskeleton related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001625 Uncertain Expressed in all bone marrow: 157.7 POLA1 NSX, p180, POLA ENSG00000101868 Polymerase (DNA directed), alpha 1, catalytic subunit X 24693919-24996986 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002947, CAB012274 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all tonsil: 7.6 POLB ENSG00000070501 Polymerase (DNA directed), beta 8 42338454-42371808 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011616, HPA049104 Supportive Uncertain Vesicles Expressed in all testis: 45.0 POLE POLE1 ENSG00000177084 Polymerase (DNA directed), epsilon, catalytic subunit 12 132623753-132687365 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058210, HPA067385 Supportive Nucleus, Plasma membrane Expressed in all bone marrow: 16.3 POLE2 DPE2 ENSG00000100479 Polymerase (DNA directed), epsilon 2, accessory subunit 14 49643555-49688422 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027555 Uncertain Supportive Nucleus but not nucleoli, Vesicles Mixed bone marrow: 7.8 PPARG NR1C3, PPARG1, PPARG2, PPARgamma ENSG00000132170 Peroxisome proliferator-activated receptor gamma 3 12287368-12434356 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004282, HPA051239, HPA063663 Uncertain Supportive Nucleus, Golgi apparatus, Vesicles Expressed in all adipose tissue: 120.2 PRDX5 ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10 ENSG00000126432 Peroxiredoxin 5 11 64318088-64321811 Enzymes, FDA approved drug targets, Mitochondrial proteins, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008661, HPA037915, HPA037916 Supportive Supportive Cytoplasm, Mitochondria Expressed in all fallopian tube: 377.8 PRKAA1 AMPKa1 ENSG00000132356 Protein kinase, AMP-activated, alpha 1 catalytic subunit 5 40759379-40798374 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005050, HPA035409, HPA064946 Supportive Supportive Nucleus Expressed in all testis: 33.1 PRKAB1 ENSG00000111725 Protein kinase, AMP-activated, beta 1 non-catalytic subunit 12 119667753-119681630 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004247, CAB005058 Supportive Supportive Cytoplasm, Nucleoli Expressed in all kidney: 33.4 PROC ENSG00000115718 Protein C (inactivator of coagulation factors Va and VIIIa) 2 127418427-127429246 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005550, CAB016721, CAB016792 Supportive Tissue enriched 10 liver: 118.0 kidney: 11.6 PROS1 PROS ENSG00000184500 Protein S (alpha) 3 93873033-93974066 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007724, HPA023974 Supportive Uncertain Nuclear membrane, Golgi apparatus Expressed in all liver: 111.3 PSMB1 HC5, PMSB1 ENSG00000008018 Proteasome (prosome, macropain) subunit, beta type, 1 6 170535117-170553341 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029635, HPA029637, CAB033911 Supportive Supportive Nucleus, Cytoplasm, Cytoskeleton (Intermediate filaments) Expressed in all tonsil: 161.6 PSMB10 beta2i, LMP10, MECL1, MGC1665 ENSG00000205220 Proteasome (prosome, macropain) subunit, beta type, 10 16 67934502-67937087 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030224, HPA030225, CAB034384 Supportive Supportive Cytoplasm, Vesicles Expressed in all lymph node: 69.4 PSMB2 HC7-I ENSG00000126067 Proteasome (prosome, macropain) subunit, beta type, 2 1 35599544-35641844 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026322, HPA026324 Uncertain Supportive Nucleus but not nucleoli Expressed in all tonsil: 35.0 PSMB5 MB1, X ENSG00000100804 Proteasome (prosome, macropain) subunit, beta type, 5 14 23016543-23035230 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049518, HPA061796 Uncertain Supportive Nucleus, Centrosome Expressed in all fallopian tube: 79.1 PSMB8 beta5i, D6S216E, LMP7, PSMB5i, RING10 ENSG00000204264 Proteasome (prosome, macropain) subunit, beta type, 8 6 32840717-32844703 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046995, HPA050327 Supportive Uncertain Vesicles, Cytoskeleton (Cytokinetic bridge) Expressed in all lymph node: 133.2 PSMB9 beta1i, LMP2, PSMB6i, RING12 ENSG00000240065 Proteasome (prosome, macropain) subunit, beta type, 9 6 32844136-32859585 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015180, HPA042818, HPA053280 Supportive Supportive Cytoplasm, Nuclear membrane Expressed in all lymph node: 183.2 PSMD1 P112, Rpn2, S1 ENSG00000173692 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 2 231056864-231172827 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB021092, HPA036736, HPA036737 Supportive Uncertain Nucleus but not nucleoli, Cytoskeleton (Actin filaments) Expressed in all smooth muscle: 44.4 PSMD2 MGC14274, P97, Rpn1, S2, TRAP2 ENSG00000175166 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 3 184298709-184309054 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045192 Uncertain Expressed in all testis: 77.6 PTGS1 COX1, PGHS-1, PTGHS ENSG00000095303 Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) 9 122370530-122395703 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002834, CAB020315 Supportive Supportive Golgi apparatus, Vesicles Tissue enhanced 0 skin: 90.8 esophagus: 63.8 PTGS2 COX2 ENSG00000073756 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 1 186671791-186680427 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000113, HPA001335 Supportive Tissue enhanced 0 bone marrow: 63.8;urinary bladder: 57.2 gallbladder: 30.9 QPRT QPRTase ENSG00000103485 Quinolinate phosphoribosyltransferase 16 29679008-29698699 Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011887 Uncertain Expressed in all kidney: 92.1 RARA NR1B1, RAR ENSG00000131759 Retinoic acid receptor, alpha 17 40309192-40357643 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA058282 Supportive Nucleus, Cytoplasm Expressed in all gallbladder: 38.1 RARB HAP, NR1B2, RRB2 ENSG00000077092 Retinoic acid receptor, beta 3 25174332-25597932 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB002617, HPA004174 Supportive Supportive Nucleus but not nucleoli Mixed placenta: 11.0 RARG NR1B3, RARC ENSG00000172819 Retinoic acid receptor, gamma 12 53210567-53232980 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA053883 Supportive Supportive Nucleus but not nucleoli Tissue enhanced 0 skin: 84.0 esophagus: 59.3 RET CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51 ENSG00000165731 Ret proto-oncogene 10 43077027-43130351 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002581, HPA008356, CAB018342 Uncertain Supportive Plasma membrane, Cytoplasm, Vesicles Tissue enriched 7 adrenal gland: 17.3 salivary gland: 2.3 RPL3 L3 ENSG00000100316 Ribosomal protein L3 22 39312882-39320389 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Ribosomal proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003365, HPA055361 Uncertain Supportive Nucleoli, Nucleus but not nucleoli, Cytoplasm Expressed in all ovary: 3288.6 RRM1 ENSG00000167325 Ribonucleotide reductase M1 11 4094707-4138876 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022093, HPA057265, HPA064297 Supportive Supportive Cytoplasm Expressed in all tonsil: 39.8 RRM2 ENSG00000171848 Ribonucleotide reductase M2 2 10122328-10131419 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056994 Uncertain Supportive Cytoplasm, Nucleus Tissue enhanced 0 bone marrow: 37.4 tonsil: 33.7 RRM2B p53R2 ENSG00000048392 Ribonucleotide reductase M2 B (TP53 inducible) 8 102204502-102239118 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006854, HPA028812 Uncertain Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all thyroid gland: 36.3 RXRA NR2B1 ENSG00000186350 Retinoid X receptor, alpha 9 134317098-134440585 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004565, CAB005352 Supportive Supportive Nucleus, Golgi apparatus Expressed in all esophagus: 19.4 RXRB H-2RIIBP, NR2B2, RCoR-1 ENSG00000204231 Retinoid X receptor, beta 6 33193588-33200688 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002003, HPA063653 Uncertain Supportive Nucleus Expressed in all fallopian tube: 24.8 RYR1 CCO, MHS, MHS1, PPP1R137, RYR ENSG00000196218 Ryanodine receptor 1 (skeletal) 19 38433699-38587564 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056416 Supportive Uncertain Golgi apparatus, Vesicles, Cytoplasm Tissue enriched 20 skeletal muscle: 300.7 esophagus: 15.0 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage-gated, type II, alpha subunit 2 165239402-165392308 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supportive Tissue enriched 18 cerebral cortex: 31.4 kidney: 1.7 SCNN1D dNaCh, ENaCdelta ENSG00000162572 Sodium channel, non-voltage-gated 1, delta subunit 1 1280436-1292029 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009540, HPA026884 Uncertain Supportive Plasma membrane, Cytoskeleton (Actin filaments) Tissue enhanced 0 testis: 7.6 duodenum: 2.4 SERPINB2 HsT1201, PAI2, PLANH2 ENSG00000197632 Serpin peptidase inhibitor, clade B (ovalbumin), member 2 18 63871692-63903890 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015480 Supportive Tissue enhanced 0 esophagus: 195.4;skin: 62.6;tonsil: 68.0 placenta: 37.0 SERPINC1 AT3, ATIII, MGC22579 ENSG00000117601 Serpin peptidase inhibitor, clade C (antithrombin), member 1 1 173903804-173917378 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001816, CAB016790, HPA024007 Supportive Tissue enriched 933 liver: 1398.1 kidney: 1.4 SERPIND1 D22S673, HC-II, HC2, HCF2, HLS2 ENSG00000099937 Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 22 20773879-20787720 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008639, HPA055767 Supportive Tissue enriched 191 liver: 389.7 placenta: 2.0 SHMT1 CSHMT, MGC15229, MGC24556, SHMT ENSG00000176974 Serine hydroxymethyltransferase 1 (soluble) 17 18327860-18363563 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023314 Uncertain Supportive Nucleus, Cytoplasm Expressed in all kidney: 192.0 SI ENSG00000090402 Sucrase-isomaltase (alpha-glucosidase) 3 164978898-165078495 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011897 Supportive Group enriched 15 duodenum: 431.2;small intestine: 362.7 rectum: 26.4 SIGMAR1 OPRS1, SR-BP1 ENSG00000147955 Sigma non-opioid intracellular receptor 1 9 34634722-34637809 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013470, HPA018002, HPA024071 Supportive Expressed in all liver: 61.0 SIRT5 ENSG00000124523 Sirtuin 5 6 13574529-13615158 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021798, HPA022002, HPA022992 Supportive Supportive Mitochondria Expressed in all heart muscle: 12.5 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm Tissue enriched 597 kidney: 365.5 testis: 0.6 SLC12A3 NCCT ENSG00000070915 Solute carrier family 12 (sodium/chloride transporter), member 3 16 56865207-56915850 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028748 Supportive Tissue enriched 134 kidney: 101.6 lymph node: 0.7 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021717-46060150 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA072058 Supportive Tissue enriched 49 cerebral cortex: 36.6 adrenal gland: 0.7 SLC22A8 OAT3 ENSG00000149452 Solute carrier family 22 (organic anion transporter), member 8 11 62989154-63015839 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044174 Supportive Tissue enriched 764 kidney: 255.1 cerebral cortex: 0.3 SLC5A2 SGLT2 ENSG00000140675 Solute carrier family 5 (sodium/glucose cotransporter), member 2 16 31483002-31490860 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041603 Supportive Tissue enriched 27 kidney: 35.2 testis: 1.3 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supportive Uncertain Mitochondria Group enriched 9 cerebral cortex: 57.7;liver: 33.4 testis: 4.8 SMOX C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO ENSG00000088826 Spermine oxidase 20 4120980-4187747 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047117 Uncertain Supportive Cytoplasm Expressed in all cerebral cortex: 23.0 SMS MRSR, SPMSY, SpS, SRS ENSG00000102172 Spermine synthase X 21940573-21994835 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029849, HPA029852 Supportive Supportive Nucleus, Cytoplasm Expressed in all prostate: 37.4 SNAP25 bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25 ENSG00000132639 Synaptosomal-associated protein, 25kDa 20 10218830-10307418 FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000360, HPA001830 Supportive Uncertain Cytoplasm, Golgi apparatus, Cytoskeleton (Actin filaments), Nucleus, Nucleoli Tissue enriched 23 cerebral cortex: 916.5 adrenal gland: 39.9 SOAT1 ACAT, SOAT, STAT ENSG00000057252 Sterol O-acyltransferase 1 1 179293714-179358680 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009533, HPA047171 Supportive Supportive Endoplasmic reticulum Tissue enriched 7 adrenal gland: 147.1 prostate: 21.7 SRC ASV, c-src, SRC1 ENSG00000197122 SRC proto-oncogene, non-receptor tyrosine kinase 20 37344685-37406050 Cancer-related genes, Cytoskeleton related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004023, HPA030875 Uncertain Supportive Plasma membrane, Cytoplasm Mixed stomach: 32.0 SSTR2 ENSG00000180616 Somatostatin receptor 2 17 73165012-73176633 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007264 Uncertain Supportive Cytoplasm Tissue enhanced 0 cerebral cortex: 11.5 spleen: 3.2 SSTR5 ENSG00000162009 Somatostatin receptor 5 16 1078781-1080142 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA066503 Supportive Plasma membrane, Nucleus Tissue enhanced 0 adrenal gland: 0.6 kidney: 0.3 SV2A KIAA0736, SV2 ENSG00000159164 Synaptic vesicle glycoprotein 2A 1 149903318-149917882 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002226, HPA007863 Supportive Supportive Cytoplasm Tissue enriched 11 cerebral cortex: 83.1 adrenal gland: 7.3 SYT2 ENSG00000143858 Synaptotagmin II 1 202590596-202710417 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030372, HPA063655 Supportive Supportive Vesicles Tissue enhanced 0 adrenal gland: 1.4;cerebral cortex: 1.1 testis: 0.6 TBXAS1 CYP5, CYP5A1, THAS, TS, TXAS, TXS ENSG00000059377 Thromboxane A synthase 1 (platelet) 7 139777051-140020325 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031257, HPA031258, HPA031259 Supportive Supportive Vesicles Mixed spleen: 34.9 TFPI EPI, LACI, TFI, TFPI1 ENSG00000003436 Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) 2 187464230-187565760 Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005575, CAB020842 Supportive Uncertain Cytoplasm, Cytoskeleton (Intermediate filaments) Expressed in all placenta: 153.0 TH DYT5b ENSG00000180176 Tyrosine hydroxylase 11 2163929-2171877 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002522, HPA061003, CAB072340 Supportive Supportive Tissue enriched 70 adrenal gland: 133.5 adipose tissue: 1.9 THRA AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3 ENSG00000126351 Thyroid hormone receptor, alpha 17 40058290-40093867 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009654, CAB023349 Uncertain Supportive Cytoplasm Expressed in all cerebral cortex: 115.1 THRB ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2 ENSG00000151090 Thyroid hormone receptor, beta 3 24117160-24495282 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002008, CAB002009, HPA061035 Uncertain Supportive Nucleus Expressed in all cerebral cortex: 19.1 TLR7 ENSG00000196664 Toll-like receptor 7 X 12867083-12890380 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059613 Supportive Mixed tonsil: 4.7 TNFRSF8 CD30, D1S166E, KI-1 ENSG00000120949 Tumor necrosis factor receptor superfamily, member 8 1 12063377-12144207 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000016, HPA032081, HPA032082 Supportive Mixed appendix: 2.0 TNFSF11 CD254, ODF, OPGL, RANKL, TRANCE ENSG00000120659 Tumor necrosis factor (ligand) superfamily, member 11 13 42562736-42608013 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009193, HPA045142 Supportive Tissue enhanced 0 lymph node: 13.2 appendix: 4.6 TNNC1 TNNC ENSG00000114854 Troponin C type 1 (slow) 3 52451102-52454070 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002450, HPA044848, HPA056897 Supportive Supportive Nucleus but not nucleoli, Cytoskeleton (Actin filaments), Mitochondria Group enriched 15 heart muscle: 4171.2;skeletal muscle: 5275.2 esophagus: 312.9 TOP1 ENSG00000198900 Topoisomerase (DNA) I 20 41028818-41124487 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009058, HPA019039 Supportive Supportive Nucleus, Nucleoli Expressed in all lymph node: 46.8 TOP1MT ENSG00000184428 Topoisomerase (DNA) I, mitochondrial 8 143304384-143359979 Enzymes, FDA approved drug targets, Mitochondrial proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001915, HPA021542 Uncertain Supportive Mitochondria Expressed in all ovary: 25.3 TOP2A TOP2 ENSG00000131747 Topoisomerase (DNA) II alpha 170kDa 17 40388516-40417950 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002448, HPA006458, HPA026773 Supportive Supportive Nucleus Tissue enhanced 0 testis: 52.0 tonsil: 35.9 TOP2B ENSG00000077097 Topoisomerase (DNA) II beta 180kDa 3 25597905-25664907 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004601, HPA024120, HPA050441 Supportive Supportive Nucleus Expressed in all urinary bladder: 45.6 TPH1 TPH, TPRH ENSG00000129167 Tryptophan hydroxylase 1 11 18017564-18042426 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB010767, HPA022483 Supportive Uncertain Cytoplasm Group enriched 9 colon: 6.7;duodenum: 7.3;rectum: 12.7;small intestine: 7.4;stomach: 10.1 prostate: 0.9 TPK1 HTPK1, PP20 ENSG00000196511 Thiamin pyrophosphokinase 1 7 144451941-144836395 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021545, HPA021849 Supportive Uncertain Vesicles Mixed duodenum: 12.9 TPO TPX ENSG00000115705 Thyroid peroxidase 2 1374223-1543711 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA007987, CAB009587 Supportive Uncertain Cytoplasm Tissue enriched 68 thyroid gland: 1821.7 spleen: 26.7 TSPO BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS ENSG00000100300 Translocator protein (18kDa) 22 43151514-43163242 Cancer-related genes, FDA approved drug targets, Mitochondrial proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011232, HPA046260 Uncertain Supportive Mitochondria, Nuclear membrane, Cytoplasm, Vesicles Expressed in all bone marrow: 241.0 TUBA1A B-ALPHA-1, FLJ25113, TUBA3 ENSG00000167552 Tubulin, alpha 1a 12 49184796-49189324 Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB008686, HPA039247, HPA043684, HPA063394 Supportive Expressed in all smooth muscle: 808.6 TUBA4A FLJ30169, H2-ALPHA, TUBA1 ENSG00000127824 Tubulin, alpha 4a 2 219249711-219278170 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004621, CAB005887, HPA039247, HPA043684, HPA063394 Supportive Expressed in all skin: 107.4 TUBB M40, MGC16435, OK/SW-cl.56, Tubb5 ENSG00000196230 Tubulin, beta class I 6 30720201-30725426 Cytoskeleton related proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005417, CAB012406, HPA043640, HPA046280 Supportive Expressed in all tonsil: 409.1 TUBB4B Beta2, TUBB2C ENSG00000188229 Tubulin, beta 4B class IVb 9 137241213-137243707 Cytoskeleton related proteins, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010880, HPA043640, HPA046280 Supportive Expressed in all testis: 517.0 TUBD1 FLJ12709, TUBD ENSG00000108423 Tubulin, delta 1 17 59859482-59892945 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004609, HPA023980, HPA027090 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all esophagus: 8.3 TUBG1 TUBG, TUBGCP1 ENSG00000131462 Tubulin, gamma 1 17 42609676-42615234 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004608, HPA043012, HPA046040 Uncertain Expressed in all testis: 100.1 TYR OCA1, OCA1A, OCAIA ENSG00000077498 Tyrosinase 11 89177452-89295759 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000079 Supportive Tissue enriched 186 skin: 18.5 adipose tissue: 0.0 VDR NR1I1, PPP1R163 ENSG00000111424 Vitamin D (1,25- dihydroxyvitamin D3) receptor 12 47841537-47943048 Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004617, HPA047740 Supportive Nucleus but not nucleoli Tissue enhanced 0 duodenum: 40.3;small intestine: 40.5 colon: 28.5 VEGFA VEGF, VEGF-A, VPF ENSG00000112715 Vascular endothelial growth factor A 6 43770184-43786487 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005429, CAB039240 Supportive Supportive Mitochondria Expressed in all thyroid gland: 285.9 VWF F8VWF ENSG00000110799 Von Willebrand factor 12 5948874-6124770 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001694, HPA001815, HPA002082, CAB072874, CAB072875 Supportive Mixed adipose tissue: 100.9 YES1 c-yes, HsT441, Yes ENSG00000176105 YES proto-oncogene 1, Src family tyrosine kinase 18 721588-812546 Cytoskeleton related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004370, HPA026480 Uncertain Supportive Plasma membrane, Cytoplasm Expressed in all placenta: 34.1